NVCR Stock Analysis: Buy, Sell, or Hold?
NVCR - NovoCure Limited Ordinary Shares
$14.84
-0.39 (-2.56%)
▼
5d:
-15.92%
30d:
-5.96%
90d:
-2.43%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 29, 2026
Smart Money Accumulation
None View Scanner →
Strength: 7.0/10
Get Alerted When NVCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NVCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NVCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NVCR is currently trading at $14.84, which is considered slightly low relative to its 30-day fair value range of $14.87 to $17.38.
Technical Outlook: Technically, NVCR is in a strong downtrend. The price is currently testing key support at $14.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NVCR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $27.14 (+82.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NVCR is in a strong downtrend. The price is currently testing key support at $14.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NVCR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $27.14 (+82.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$14.87 -
$17.38
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding NVCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 82.9% below Wall St target ($27.14)
- CAUTION: 5-day price weakness (-15.9%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$14.87 -
$17.38
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$14.83
Resistance Level
$21.45
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-16.22
Wall Street Target
$27.14
(+82.9%)
Revenue Growth (YoY)
15.6%
Earnings Growth (YoY)
-6.0%
Profit Margin
-21.2%
Share & Embed Analysis
Last updated: August 02, 2026 6:25 AM ET
Data refreshes hourly during market hours. Next update: 7:25 AM
Data refreshes hourly during market hours. Next update: 7:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Mukund Paravasthu
SELL
43246 shares
2026-03-05
Christoph Brackmann
SELL
6412 shares
2026-03-04
Frank X Leonard
SELL
5607 shares
2026-03-04
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$72 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$86 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
Advanced NVCR Option Strategies
Professional options setups generated by AI based on today's NVCR price and gamma walls.
